Natco Pharma Ltd - Company Profile
Powered by
All the data and insights you need on Natco Pharma Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Natco Pharma Ltd Strategy Report
- Understand Natco Pharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Natco Pharma Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
08 Aug 2022 | Eyestem Research Raises USD6.4 Million in Series A Financing | Venture Financing |
Alkem Laboratories Ltd
Endiya Partners
Kotak Private Equity Group
Natco Pharma Ltd
Biological E Ltd
|
Eyestem Research Pvt Ltd
|
20 Jan 2022 | Natco Pharma Enters into Licensing Agreement with Medicines Patent Pool for COVID-19 Treatment | Licensing Agreement |
Natco Pharma Ltd
|
Medicines Patent Pool
|
14 Dec 2021 | Natco Pharma Acquires DASH Pharma | Acquisition |
Natco Pharma Ltd
|
DASH Pharmaceuticals LLC
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer